Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Helicobacter Pylori Tests Market Report Overview

The Helicobacter Pylori Tests market size was valued at $338.5 million in 2023. The Helicobacter Pylori Tests market will grow at a CAGR of more than 2% from 2023 to 2033. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies such as peptic ulcer disease, gastric MALT lymphoma and gastric cancer as 89% of all gastric cancers are related to H. pylori infection.

Helicobacter Pylori Tests Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights on the Helicobacter Pylori Tests Market Forecast, Download a Free Sample Report

The Helicobacter Pylori Tests market research report highlights the market behavior that will help identify quantitative market trends within diagnostic imaging therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of Helicobacter Pylori Tests across labs, which will help in identifying untapped market opportunities. The Helicobacter Pylori Tests market model also discusses the detailed impact of COVID-19 on the Helicobacter Pylori Tests market for 2020 and beyond.

Helicobacter Pylori Tests Market Dynamics

The use of the IHC test has increased as it is a highly reliable and sensitive method for the diagnosis of H. pylori infection. The market for H. pylori tests will grow across all regions during the forecast period. This growth is owing to factors such as increasing incidences of gastric cancer and peptic ulcer, improved accessibility, rising awareness of H. pylori test in emerging economies, and technological advancements.

However, the market will face challenges in terms of cost of tests and equipment such as urea breath tests. Challenges such as social inequalities may also limit access to tests. Urea breath tests and stool antigen tests among non-invasive tests and rapid urease tests among invasive tests will grow in number soon.

Buy the Full Report for Additional Helicobacter Pylori Tests Market Dynamics, Download a Free Sample Report

Helicobacter Pylori Tests Market Segments

The key segments in the Helicobacter Pylori Tests market are Helicobacter pylori Breath Tests, Helicobacter pylori Feces Tests, Helicobacter pylori Immunohistochemical (IHC) Tests, Helicobacter pylori Other Tests, Helicobacter pylori Rapid Urease Tests, and Helicobacter pylori Serology Enzyme Immuno Assay (EIA) Tests. In 2023, Helicobacter pylori Breath Tests segment dominated the market share. The segment will continue to dominate the market during the forecast period.

Helicobacter Pylori Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights in the Helicobacter Pylori Tests Market, Download a Free Sample Report

Helicobacter Pylori Tests Market Segmentation by Regions

The key regions in the Helicobacter Pylori Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, Europe emerged as the leading regional market.

The H. pylori testing market will expand to a majority of European countries in the future and the market share for urea breath test, feces test, and RUT is expected to rise as they are recommended by European study groups for testing H. pylori infection. The updated European Helicobacter Study Group (EHSG) Fourth Maastricht/Florence Consensus Conference guidelines suggest that people should be tested for H pylori. Eradication of H pylori has been recommended for conditions including dyspepsia, unexplained iron deficiency anemia, gastric cancer, and idiopathic thrombocytopenic purpura.

Helicobacter Pylori Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the Helicobacter Pylori Tests Market, Download A Free Sample Report

Helicobacter Pylori Tests Market – Competitive Landscape

The key companies in the Helicobacter Pylori Tests market are Meridian Bioscience Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, bioMerieux SA, and Avanos Medical Inc among others. In 2023, Meridian Bioscience Inc accounted for the highest Helicobacter Pylori Tests market share and value.

Helicobacter Pylori Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Helicobacter Pylori Tests Market, Download a Free Sample Report

Segments Covered in this Report.

Helicobacter Pylori Tests Segment Outlook ($ Million, 2015-2033)

• Helicobacter pylori Breath Tests
• Helicobacter pylori Feces Tests
• Helicobacter pylori Immunohistochemical (IHC) Tests
• Helicobacter pylori Other Tests
• Helicobacter pylori Rapid Urease Tests
• Helicobacter pylori Serology Enzyme Immuno Assay (EIA) Tests

Helicobacter Pylori Tests Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are:

Currently marketed Helicobacter Pylori Tests market and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Helicobacter Pylori Tests market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Helicobacter Pylori Tests market.
• Competitive dynamics insights and trends provided for the Helicobacter Pylori Tests market.

Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Avanos Medical Inc, Meridian Bioscience Inc, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, bioMerieux SA, Bio-Rad Laboratories Inc,Siemens AG, Trinity Biotech Plc, Merck KGaA, Sekisui Chemical Ltd, Sentinel CH. SpA, Abbott Laboratories, Quidelortho Corp, TECHLAB Inc, Agilent Technologies Inc, Cardinal Health Inc, Biocare Medical LLC, Danaher Corp, Werfen Life Group SAU, MP Biomedicals LLC, GI Supply Inc, Serim Research Corporation, Polymedco Inc, and Others..

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:

• CMO executives who must have a deep understanding of the Helicobacter Pylori Tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

• Understand the impact of COVID-19 on Helicobacter Pylori Tests.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Helicobacter Pylori Tests.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Helicobacter Pylori Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Helicobacter Pylori Tests market from 2015-2033.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.